Precision Medicine News and Research

RSS

Myriad Women’s Health to present two new studies highlighting performance of its prenatal tests

Myriad Genetics, Inc., a global leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present results from two important studies at the 2019 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting that highlight the performance of its prenatal tests.

3 Apr 2019

Photonics-based tiny device could one day play key role in personalized medicine

In the not-too-distant future, each of us may have a simple device - small enough for our nightstand or our pocket - that keeps us apprised of our level of health, identifies even trace amounts of undesirable biomarkers in our blood or saliva and serves as an early-warning system for diseases.

3 Apr 2019

Scientists identify biomarkers to predict risk of atrial fibrillation

Scientists at the University of Navarra (Spain), in collaboration with clinicians from the University Hospital of Donostia, have identified two biomarkers associated with the risk of suffering atrial fibrillation, a cardiac ailment that affects more than 33.5 million people in the world.

2 Apr 2019

Research reveals genomic basis of acute erythroid leukemia

Acute erythroid leukemia is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital that appears today in the journal Nature Genetics.

30 Mar 2019

New Hasso Plattner Institute for Digital Health launched at Mount Sinai

The Mount Sinai Health System and the Hasso Plattner Institute today announced an affiliation that brings together industry leaders with combined expertise in health care delivery, health sciences, biomedical and digital engineering, machine learning and artificial intelligence to rapidly develop digital health products with real-time predictive and preventive capabilities that empower patients and health care providers, and improve health and health outcomes.

29 Mar 2019

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

29 Mar 2019

New computer program predicts risk of life-threatening arrhythmias

Combining a wealth of information derived from previous studies with data from more than 500 patients, an international team led by researchers from Johns Hopkins has developed a computer-based set of rules that more accurately predicts when patients with a rare heart condition might benefit--or not--from lifesaving implanted defibrillators.

28 Mar 2019

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action, research led by the University of Michigan Rogel Cancer Center found.

27 Mar 2019

Synthetic biological logic gate could one day be used to modify cellular function

Genes in living cells are activated - or not - by proteins called transcription factors. The mechanisms by which these proteins activate certain genes and deactivate others play a fundamental role in many biological processes.

26 Mar 2019

Understanding genetic interactions holds key to new personalized therapies

When the Human Genome Project was completed, in 2003, it opened the door to a radical new idea of health - that of personalized medicine, in which disease risk and appropriate treatment would be gleaned from one's genetic makeup.

25 Mar 2019

A new way to visualize the immune cell "landscape" of bowel cancer tumors

University of Otago scientists have discovered a way to view the immune cell "landscape" of bowel cancer tumours, paving the way towards more individualised medicine and treatment for many other diseases in future.

22 Mar 2019

Partnership aims at establishing best practices to promote diversity in clinical trials

Spencer Hoover, vice president and executive director of the Henry Ford Cancer Institute, is co-author of a manuscript published in the Journal of Oncology Practice aimed at establishing best practices to promote diversity in clinical trials.

22 Mar 2019

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.

21 Mar 2019

New computer program developed by TGen lights up cancer-causing genetic mutations

By conjuring the spell "Lumos!" wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program developed by the Translational Genomics Research Institute, "light up" cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.

21 Mar 2019

Bruker showcases new analytical systems and applied market solutions at Pittcon 2019

At Pittcon 2019, Bruker this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions.

From Bruker 19 Mar 2019

TGen and ABL sign agreement to distribute new TB test technology

n an important step toward eradicating tuberculosis, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories, to market and distribute TGen's patented Next Generation Sequencing-based TB test technology.

19 Mar 2019

Latest advances and perspectives of all AI types used in pharmaceutical R&D

The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.

19 Mar 2019

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

The nation's first African-American Neuroscience Research Initiative, aimed at ensuring that genomic research and neuroscience studies are representative of individuals across all populations including African ancestry, launched today.

19 Mar 2019

Columbia researchers explore molecular mechanisms of treatment-resistant depression

Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.

14 Mar 2019

Access to real-time genotype data influences prescriber behavior after PCI

Today, in a late-breaking featured clinical research session at the American College of Cardiology Scientific Sessions 2018, researchers from Penn Medicine present first-of-its-kind data on the impact of real-time CYP2C19 genotype results when prescribing antiplatelet drugs in the clinic.

13 Mar 2019

Precision Medicine News and Research

Myriad Women’s Health to present two new studies highlighting performance of its prenatal tests

Photonics-based tiny device could one day play key role in personalized medicine

Scientists identify biomarkers to predict risk of atrial fibrillation

Research reveals genomic basis of acute erythroid leukemia

New Hasso Plattner Institute for Digital Health launched at Mount Sinai

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

New computer program predicts risk of life-threatening arrhythmias

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

Synthetic biological logic gate could one day be used to modify cellular function

Understanding genetic interactions holds key to new personalized therapies

A new way to visualize the immune cell "landscape" of bowel cancer tumors

Partnership aims at establishing best practices to promote diversity in clinical trials

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

New computer program developed by TGen lights up cancer-causing genetic mutations

Bruker showcases new analytical systems and applied market solutions at Pittcon 2019

TGen and ABL sign agreement to distribute new TB test technology

Latest advances and perspectives of all AI types used in pharmaceutical R&D

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

Columbia researchers explore molecular mechanisms of treatment-resistant depression

Access to real-time genotype data influences prescriber behavior after PCI

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News